Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Researchers have found a new class of antibodies to treat malaria ... breakthrough that could help development of a new next-generation antimalarial interventions," Cristina Donini told DW.

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.